Finance

Lists
Outlook: 53.8% bullish·15.4% bearish
Go to analysis
OCUL:NASDAQ
Ocular Therapeutix Inc
US$6.21
-1.11%
(-0.070) 1D
US$6.26
+0.83% (+0.052)
After hours
Closed: ኖቬም 13, 4:00:00 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCUL...
Open
US$6.27
High
US$6.38
Low
US$6.00
Mkt. cap
1.37 ቢ
Avg. vol.
3.03 ሚ
Volume
2.49 ሚ
52-wk high
US$16.44
52-wk low
US$6.00
EPS
-US$1.46
Beta
1.22
Shares outstanding
220.02 ሚ
No. of employees
325
Open
US$6.27
High
US$6.38
Low
US$6.00
Mkt. cap
1.37 ቢ
Avg. vol.
3.03 ሚ
Volume
2.49 ሚ
52-wk high
US$16.44
52-wk low
US$6.00
EPS
-US$1.46
Beta
1.22
Shares outstanding
220.02 ሚ
No. of employees
325
News stories
From web sources and news partners
Investing.com
Investing.com
·
ከ12 ሰዓቶች በፊት
Ocular Therapeutix stock hits 52-week low at 6.0 USD
Yahoo Finance Singapore
Yahoo Finance Singapore
·
ከ2 ቀናት በፊት
Ocular Therapeutix (OCUL) On Phase 3 AMD Win And Why The Valuation Debate Persists
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, ማሣቹሰትስ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryPharmaceutical industry
Websiteocutx.com
Analyst ratings
Based on 8 analysts giving stock ratings to OCUL in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for OCUL in the last 3 months.
Highest
Current US$6.21
US$31.00 (+399.19%)
Average
US$25.14 (+304.83%)
Lowest
US$14.00 (+125.44%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$28.00
+350.9%
11/10/2026
Serge Belanger
Needham
Buy
Maintained
US$18.00
+189.9%
11/10/2026
Lisa Walter
RBC Capital
Buy
Reiterated
US$30.00
+383.1%
11/09/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
US$27.00
+334.8%
11/09/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$31.00
+399.2%
10/12/2026
Unknown Analyst
UBS
Buy
Initiated
US$14.00
+125.4%
10/11/2026
Alice Nettleton
UBS
Buy
Initiated
US$14.00
+125.4%
10/11/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/25/2026
William Maughan
Clear Street
Buy
Reiterated
US$28.00
+350.9%
08/18/2026
Tara Bancroft
TD Cowen
Buy
Maintained
US$20.00
+222.1%
08/03/2026
Daniil Gataulin
Chardan Capital
Buy
Maintained
US$23.00
+270.4%
06/25/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
US$30.00
+383.1%
06/18/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
-
-
02/17/2026
Clara Dong
Jefferies
Buy
Maintained
US$28.00
+350.9%
02/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
13.25 ሚ
10.78 ሚ
13.48 ሚ
12.87 ሚ
Cost of goods sold
52.39 ሚ
67.54 ሚ
56.15 ሚ
76.24 ሚ
Cost of revenue
52.39 ሚ
67.54 ሚ
56.15 ሚ
76.24 ሚ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.62 ሚ
36.58 ሚ
39.44 ሚ
34.49 ሚ
Operating expense
30.62 ሚ
36.58 ሚ
39.44 ሚ
34.49 ሚ
Total operating expenses
83.01 ሚ
104.12 ሚ
95.58 ሚ
110.73 ሚ
Operating income
-69.76 ሚ
-93.34 ሚ
-82.11 ሚ
-97.86 ሚ
Other non operating income
624.00 ሺ
1.46 ሚ
689.00 ሺ
912.00 ሺ
EBT including unusual items
-64.65 ሚ
-88.61 ሚ
-78.76 ሚ
-94.78 ሚ
EBT excluding unusual items
-64.62 ሚ
-88.61 ሚ
-78.76 ሚ
-94.78 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-64.65 ሚ
-88.61 ሚ
-78.76 ሚ
-94.78 ሚ
Net profit margin
-487.95%
-821.62%
-584.51%
-736.23%
Earnings per share
-0.29
-0.40
-0.35
-0.42
Interest and investment income
7.34 ሚ
6.05 ሚ
5.45 ሚ
4.98 ሚ
Interest expense
-2.83 ሚ
-2.78 ሚ
-2.79 ሚ
-2.81 ሚ
Net interest expenses
4.51 ሚ
3.27 ሚ
2.66 ሚ
2.16 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
-68.51 ሚ
-92.06 ሚ
-80.26 ሚ
-95.43 ሚ
Gain or loss from assets sale
-
4.87 ሚ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች